Barclays’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$479K Sell
90,300
-111,545
-55% -$688K ﹤0.01% 3213
2025
Q4
$1.56M Buy
201,845
+33,470
+20% +$298K ﹤0.01% 3107
2025
Q3
$1.49M Sell
168,375
-25,268
-13% -$188K ﹤0.01% 3108
2025
Q2
$804K Buy
193,643
+151,495
+359% +$949K ﹤0.01% 3483
2025
Q1
$254K Sell
42,148
-19,297
-31% -$118K ﹤0.01% 3914
2024
Q4
$318K Buy
61,445
+5,737
+10% +$22.6K ﹤0.01% 4087
2024
Q3
$167K Buy
55,708
+47,094
+547% +$128K ﹤0.01% 4383
2024
Q2
$25.7K Sell
8,614
-22,447
-72% -$185K ﹤0.01% 4394
2024
Q1
$367K Buy
31,061
+30,000
+2,828% +$347K ﹤0.01% 3777
2023
Q4
$8.64K Sell
1,061
-3,786
-78% -$27.2K ﹤0.01% 4980
2023
Q3
$39.4K Sell
4,847
-21,214
-81% -$204K ﹤0.01% 3962
2023
Q2
$194K Buy
26,061
+24,999
+2,354% +$173K ﹤0.01% 3260
2023
Q1
$5.29K Hold
1,062
﹤0.01% 4810
2022
Q4
$5.13K Sell
1,062
-1,022
-49% -$5.02K ﹤0.01% 4998
2022
Q3
$21K Buy
2,084
+897
+76% +$12.5K ﹤0.01% 4050
2022
Q2
$16K Sell
1,187
-2,319
-66% -$36.9K ﹤0.01% 4491
2022
Q1
$60K Sell
3,506
-13,930
-80% -$240K ﹤0.01% 4044
2021
Q4
$429K Buy
17,436
+11,457
+192% +$362K ﹤0.01% 3267
2021
Q3
$220K Sell
5,979
-54
-0.9% -$1.98K ﹤0.01% 3569
2021
Q2
$295K Sell
6,033
-5,936
-50% -$247K ﹤0.01% 3360
2021
Q1
$355K Buy
11,969
+7,314
+157% +$205K ﹤0.01% 3400
2020
Q4
$119K Sell
4,655
-1,867
-29% -$37.5K ﹤0.01% 4055
2020
Q3
$95K Sell
6,522
-1,658
-20% -$27.4K ﹤0.01% 4282
2020
Q2
$168K Buy
+8,180
New +$216K ﹤0.01% 4192
2020
Q1
Sell
-37
Closed -$1K 6482
2019
Q4
$1K Sell
37
-532
-93% -$7.65K ﹤0.01% 6283
2019
Q3
$9K Sell
569
-15,415
-96% -$250K ﹤0.01% 6381
2019
Q2
$289K Buy
15,984
+10,960
+218% +$248K ﹤0.01% 4789
2019
Q1
$178K Buy
5,024
+2,554
+103% +$101K ﹤0.01% 4909
2018
Q4
$99K Sell
2,470
-2,500
-50% -$153K ﹤0.01% 5049
2018
Q3
$432K Buy
4,970
+4,647
+1,439% +$462K ﹤0.01% 4396
2018
Q2
$27K Buy
+323
New +$19.8K ﹤0.01% 6024
2018
Q1
Sell
-3
Closed 7362
2017
Q4
$0 Sell
3
-72
-96% -$3.25K ﹤0.01% 7150
2017
Q3
$4K Buy
+75
New +$3.54K ﹤0.01% 6520
2016
Q3
Sell
-258
Closed -$4K 6815
2016
Q2
$4K Buy
+258
New +$4.54K ﹤0.01% 5807
2016
Q1
Sell
-17
Closed 6466
2015
Q4
$0 Sell
17
-1,041
-98% -$24.7K ﹤0.01% 6630
2015
Q3
$13K Buy
1,058
+1,002
+1,789% +$79.3K ﹤0.01% 5671
2015
Q2
$5K Sell
56
-82
-59% -$8.67K ﹤0.01% 6466
2015
Q1
$17K Sell
138
-136
-50% -$14.3K ﹤0.01% 5922
2014
Q4
$30K Sell
274
-18
-6% -$1.95K ﹤0.01% 6064
2014
Q3
$28K Sell
292
-252
-46% -$26.4K ﹤0.01% 6269
2014
Q2
$59K Buy
544
+131
+32% +$14.2K ﹤0.01% 5825
2014
Q1
$50K Sell
413
-46
-10% -$7.34K ﹤0.01% 5999
2013
Q4
$60K Sell
459
-512
-53% -$67.3K ﹤0.01% 6060
2013
Q3
$140K Buy
971
+908
+1,441% +$159K ﹤0.01% 5351
2013
Q2
$10K Buy
+63
New +$7.59K ﹤0.01% 7142

Other funds holding VSTM

Barclays's VSTM Position: Q1 2026 in Review

Barclays reduced its Verastem (VSTM) stake by 55% in Q1 2026, selling an estimated $688K and leaving 90,300 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

Barclays first reported a position in VSTM in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.56M in Q4 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Barclays held 90,300 shares of Verastem worth $479K as of Q1 2026.
  • Barclays sold 111,545 Verastem shares in Q1 2026, an estimated $688K.
  • Verastem made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3213 holding.
  • Barclays first reported a position in Verastem in Q2 2013 and has held it in 45 quarters since.
  • Barclays's Verastem position peaked at $1.56M in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.